orphantechnologies.com orphantechnologies.com

ORPHANTECHNOLOGIES.COM

Orphan Technologies

Legal notice and privacy policy. News & Events. Legal notice and privacy policy. News & Events. Get to your HC goal and reducing dietary restrictions. To develop an enzyme replacement therapy for homocystinuria. Have a normal social life. To helping you reduce the risk of serious health events. While patients’ symptoms vary, homocystinuria can increase patients’ risk for cardiovascular, skeletal, ocular, and neuropsychiatric issues. Hallmark symptoms of homocystinuria include ocular symptoms su...

http://www.orphantechnologies.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR ORPHANTECHNOLOGIES.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.5 out of 5 with 13 reviews
5 star
7
4 star
5
3 star
1
2 star
0
1 star
0

Hey there! Start your review of orphantechnologies.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

3.3 seconds

FAVICON PREVIEW

  • orphantechnologies.com

    16x16

  • orphantechnologies.com

    32x32

  • orphantechnologies.com

    64x64

  • orphantechnologies.com

    128x128

  • orphantechnologies.com

    160x160

  • orphantechnologies.com

    192x192

  • orphantechnologies.com

    256x256

CONTACTS AT ORPHANTECHNOLOGIES.COM

Domains By Proxy, LLC

Registration Private

Domain●●●●●●xy.com

14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309

Sco●●●ale , Arizona, 85260

United States

1.48●●●●2599
1.48●●●●2598
OR●●●●●●●●●●●●●●●●●●●●@domainsbyproxy.com

View this contact

Domains By Proxy, LLC

Registration Private

Domain●●●●●●xy.com

14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309

Sco●●●ale , Arizona, 85260

United States

1.48●●●●2599
1.48●●●●2598
OR●●●●●●●●●●●●●●●●●●●●@domainsbyproxy.com

View this contact

Domains By Proxy, LLC

Registration Private

Domain●●●●●●xy.com

14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309

Sco●●●ale , Arizona, 85260

United States

1.48●●●●2599
1.48●●●●2598
OR●●●●●●●●●●●●●●●●●●●●@domainsbyproxy.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2010 December 28
UPDATED
2011 December 22
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 14

    YEARS

  • 10

    MONTHS

  • 11

    DAYS

NAME SERVERS

1
ns01.domaincontrol.com
2
ns02.domaincontrol.com

REGISTRAR

GODADDY.COM, LLC

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

SCORE

6.2

PAGE TITLE
Orphan Technologies | orphantechnologies.com Reviews
<META>
DESCRIPTION
Legal notice and privacy policy. News & Events. Legal notice and privacy policy. News & Events. Get to your HC goal and reducing dietary restrictions. To develop an enzyme replacement therapy for homocystinuria. Have a normal social life. To helping you reduce the risk of serious health events. While patients’ symptoms vary, homocystinuria can increase patients’ risk for cardiovascular, skeletal, ocular, and neuropsychiatric issues. Hallmark symptoms of homocystinuria include ocular symptoms su...
<META>
KEYWORDS
1 skip to content
2 toggle navigation
3 linkedin
4 homocystinuria
5 overview
6 patient resources
7 publications
8 management team
9 board of directors
10 partnering
CONTENT
Page content here
KEYWORDS ON
PAGE
skip to content,toggle navigation,linkedin,homocystinuria,overview,patient resources,publications,management team,board of directors,partnering,news,events,committed,to helping you,manage daily life,2018 orphan technologies
SERVER
Apache
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Orphan Technologies | orphantechnologies.com Reviews

https://orphantechnologies.com

Legal notice and privacy policy. News & Events. Legal notice and privacy policy. News & Events. Get to your HC goal and reducing dietary restrictions. To develop an enzyme replacement therapy for homocystinuria. Have a normal social life. To helping you reduce the risk of serious health events. While patients’ symptoms vary, homocystinuria can increase patients’ risk for cardiovascular, skeletal, ocular, and neuropsychiatric issues. Hallmark symptoms of homocystinuria include ocular symptoms su...

INTERNAL PAGES

orphantechnologies.com orphantechnologies.com
1

Press Releases | Orphan Technologies

http://www.orphantechnologies.com/media/press-releases

Orphan Technologies to develop new treatment for life-threatening metabolic disorder from the University of Colorado. February 20, 2013. St George’s and Orphan Technologies enter licensing agreement to create new treatment for rare and deadly disorders. February 5, 2013.

2

In-Licensing | Orphan Technologies

http://www.orphantechnologies.com/in-licensing

Orphan Technologies actively seeks in-licensing and acquisitions opportunities. We are looking to expand our pipeline with new innovative products targeting rare and ultra-rare diseases. We welcome early stage concepts and established clinical programs, as well as small molecules and biological products. If you are interested in exploring potential collaborative opportunities with us, please contact us at- BD@orphantechnologies.com.

3

Pipeline | Orphan Technologies

http://www.orphantechnologies.com/pipeline

Derived from a combination of in-licensed patents from academia and company-sponsored research initiatives, Orphan Technologies’ rapidly growing pipeline includes several breakthrough programs to provide life-changing therapies for rare, life-threatening diseases with unmet medical needs. OT-15 – MNGIE. OT-58 – Homocystinuria.

4

Careers | Orphan Technologies

http://www.orphantechnologies.com/careers

At Orphan Technologies we continuously work to research and develop medicines for patients suffering from rare and ultra-rare diseases. As we enter new stages in our clinical development and our pipeline expands, we will offer extraordinary and meaningful career opportunities that will help you to develop and expand your career while making a true difference in people’s lives. We are encouraging success and providing rewards to those who work here.

5

Partnerships | Orphan Technologies

http://www.orphantechnologies.com/partnering/partnerships

Scientific breakthrough is most commonly an outcome of collaboration. We have existing fruitful and long-term collaborations with world-leading academic centers around the globe. Orphan Technologies has licensed a technology from the University of Colorado. St George’s University of London. Orphan Technologies has licensed from St George’s University of London.

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL PAGES IN THIS WEBSITE

6

LINKS TO THIS WEBSITE

wdomachzbetonu.blog.pl wdomachzbetonu.blog.pl

Choroby rzadkie | W domach z betonu...

http://wdomachzbetonu.blog.pl/choroby-rzadkie

W domach z betonu…. Blog w wersji audio. Dziś W domach z betonu pierwszy wywiad z niezwykłą osobą – blogerką. Osobą, która jako jedyna w Polsce, w języku polskim opisuje choroby rzadkie. Osobą z którą miałam przyjemność spotkać się w Krakowie. Podczas mojego pobytu w klinice. To Kasia Ziaja. Co to są choroby rzadkie? Według amerykańskiego aktu „Orphan Drug act 2002″, choroby rzadkie (ang. rare diseases. Lub rzadkie zaburzenia (ang. rare disorders. W Stanach Zjednoczonych Ameryki, są definiowane jako:.

chorobyrzadkie.blogspot.com chorobyrzadkie.blogspot.com

Choroby rzadkie: (ultra)rzadkie

http://chorobyrzadkie.blogspot.com/p/ultrarzadkie.html

Pojęcie "choroby ultrarzadkiej" (ang. ultra-rare disease. Wprowadzamy na potrzeby Bois dentelle - grupy ludzi z chorobami ultrarzadkimi i SWAN. Ale jest pojęciem aktualnym i stosowanym. Co to są choroby rzadkie? Według amerykańskiego aktu "Orphan Drug act 2002", choroby rzadkie (ang. rare diseases. Lub rzadkie zaburzenia (ang. rare disorders. W Stanach Zjednoczonych Ameryki, są definiowane jako:. Takie, które dotyczą niewielkich populacji pacjentów, zazwyczaj mniejszych niż 200.000 osób". Około 80% ma po...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL LINKS TO THIS WEBSITE

2

OTHER SITES

orphantastico.com orphantastico.com

Default OaO Sedo Frameset

Device does not support frames.

orphantasticos.com orphantasticos.com

Default OaO Sedo Frameset

Device does not support frames.

orphantastics.com orphantastics.com

Default OaO Sedo Frameset

Device does not support frames.

orphantebpars.com orphantebpars.com

Orphan Teb Pars

Content on this page requires a newer version of Adobe Flash Player. Welcome to Orphan Teb Pars. Orphan Teb Pars as a private company was established to position the new options of treatment in Iran pharmaceutical field. Our major goal is making health accessible to all as we aim Iranian people to become one of the healthiest individuals. Currently, we want to supply pharmaceutical and medical device products from reputable multinational companies in Iran. About Orphan Teb Pars. Sales and Marketing Dept.

orphantech.com orphantech.com

Orphantech.com - Retro Gaming and Musings - Home

Orphantech.com - Retro Gaming and Musings. Orphantech.com - Retro Gaming and Musings. Reviews, musings and new software for classic computer platforms. Create a free website.

orphantechnologies.com orphantechnologies.com

Orphan Technologies

Legal notice and privacy policy. News & Events. Legal notice and privacy policy. News & Events. Get to your HC goal and reducing dietary restrictions. To develop an enzyme replacement therapy for homocystinuria. Have a normal social life. To helping you reduce the risk of serious health events. While patients’ symptoms vary, homocystinuria can increase patients’ risk for cardiovascular, skeletal, ocular, and neuropsychiatric issues. Hallmark symptoms of homocystinuria include ocular symptoms su...

orphantheband.com orphantheband.com

• • • Orphan Is With You • • •

Click here to proceed.

orphantherapeutics.com orphantherapeutics.com

Orphan Therapeutics - Home

3 Werner Way, Suite 210. Orphan Therapeutics, LLC. December 7, 2015. Mallinckrodt plc Discusses R&D Initiatives, Company Outlook at Investor Briefing. April 16, 2015. Mallinckrodt completes acquisition of Ikaria. April 23, 2012. March 30, 2010. Acquires New Drug Application for Lucassin. Investigational New Drug Application Also Acquired. 3 Werner Way, Suite 210.

orphanthreads.com orphanthreads.com

Orphan Threads, Inc

orphantom.deviantart.com orphantom.deviantart.com

orPHANTOM (Elena) - DeviantArt

Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 6 Years. This deviant's full pageview. Last Visit: 152 weeks ago. This is the place where you can personalize your profile! Favorit...

orphantoons.wordpress.com orphantoons.wordpress.com

The Home For Orphan Toons | orphan toon: an animated film forgotten by time, either through censorship or simple neglect

The Home For Orphan Toons. 124; Comments RSS. WHEN’S IT GONNA GET HERE? BRING ON THE POP CULTURE PARADE! 8220;Makes A Guy Sore! 8221;: Confirmation from Classic Media. Orphan Toon Musings Beany, Cecil and “Bats”. 8220;Swing Out, Now”: My Take On L’IL OL’ BOSKO AND THE PIRATES (1937). JAMMIN’ AT THE LILY PAD: The Music Comes Full Circle With The “Bosko Trilogy”. And The Winner Is! On Orphan Toon Musings Beany, Cec…. Topicco – Blog…. On Orphan Toon Musings–…. NOW JUST A DARN MIN…. WHEN’S IT GONNA GET HERE?